Curaleaf Holdings Dividend

Dividend criteria checks 0/6

Curaleaf Holdings does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	2.3%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-CA$0.31
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Jan 19

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CURA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CURA's dividend payments have been increasing.

Dividend Yield vs Market

Curaleaf Holdings Dividend Yield vs Market

How does CURA dividend yield compare to the market?
Segment	Dividend Yield
Company (CURA)	n/a
Market Bottom 25% (CA)	1.8%
Market Top 25% (CA)	6.4%
Industry Average (Pharmaceuticals)	2.3%
Analyst forecast in 3 Years (CURA)	n/a

Notable Dividend: Unable to evaluate CURA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CURA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CURA's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CURA has not reported any payouts.

Curaleaf Holdings Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Curaleaf Holdings, Inc. (TSX:CURA) completed the acquisition of Northern Green Canada Inc. (NGC).

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Curaleaf Holdings, Inc. to Report Q1, 2024 Results on May 09, 2024

Curaleaf Holdings, Inc. (TSX:CURA) signed a deal to acquire Northern Green Canada Inc. (NGC).

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix

Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 36%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Curaleaf Holdings, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Executive Vice-Chairman recently sold CA$860k worth of stock

Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Curaleaf Expands Brand Portfolio with Launch of Zero Proof ™ Cannabis-Infused Drinkables

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Curaleaf Holdings, Inc.'s Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

Second quarter 2023 earnings: EPS misses analyst expectations

Curaleaf Holdings, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Curaleaf Holdings, Inc. Unveils Strategic National Rebrand of Select

New minor risk - Shareholder dilution

Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

Consensus EPS estimates fall by 66%

Forecast breakeven date moved forward to 2023

Full year 2022 earnings: Revenues in line with analyst expectations

Less than half of directors are independent

Curaleaf Holdings, Inc. Announces Closure of Operations in California, Colorado and Oregon

Forecast to breakeven in 2025

Less than half of directors are independent

Curaleaf Holdings, Inc. Announces Expansion of BlueKudu Infused Chocolate Flavors Available on Florida Retail Menus

Curaleaf Holdings, Inc. Announces the Launch of Adult-Use Sales At Its Bordentown, New Jersey Location

Curaleaf Holdings Relocates Deerfield, IL Dispensary and Opens Doors to Adult-Use Customers

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) completed the acquisition of Tryke Companies, LLC for approximately $180 million.

Executive Vice-Chairman recently sold CA$160k worth of stock

We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

No longer forecast to breakeven

Consensus EPS estimates fall by 42%

No longer forecast to breakeven

Curaleaf Holdings, Inc., Annual General Meeting, Sep 08, 2022

Curaleaf Holdings, Inc. Announces Management Appointments

Curaleaf Holdings, Inc. Launches Plant Precision, New Product Line Targeting Specific Health and Wellness Categories

Consensus forecasts updated

Curaleaf Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

First quarter 2022 earnings: EPS exceeds analyst expectations

Curaleaf Holdings, Inc. Reports Impairment Loss for the Quarter Ended March 21, 2022

Curaleaf Holdings, Inc. Announces Executive Changes

Consensus forecasts updated

Forecast breakeven date pushed back to 2023

Curaleaf Holdings, Inc Expands Product Offerings With Launch of BlueKudu Chocolates in Florida

Curaleaf Holdings, Inc., Annual General Meeting, Jun 23, 2022

Curaleaf Holdings, Inc. Announces its Select Brand Launches Limited-Edition Cliq Elite Live Strain in California

Curaleaf Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Interim Chief Financial Officer exercised options to buy CA$851k worth of stock.

Curaleaf Holdings, Inc. Reports Impairment of Intangible Assets for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS exceeds analyst expectations

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Bloom Dispensaries.

Curaleaf Holdings, Inc. (CNSX:CURA) entered into a definitive agreement to acquire Bloom Dispensaries for approximately $210 million.

Curaleaf Holdings, Inc. (CNSX:CURA) agreed to acquire Natural Remedy Patient Center, LLC for $13 million.

Curaleaf Holdings, Inc. announced that it has received $475 million in funding

Curaleaf Holdings, Inc. Launches Select X Bites

Third quarter 2021 earnings released: US$0.081 loss per share (vs US$0.015 loss in 3Q 2020)

Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

Director recently sold CA$1.4m worth of stock

Curaleaf Holdings, Inc. Announces the Release of Cliq by Select

Second quarter 2021 earnings released

Curaleaf Holdings, Inc. (CNSX:CURA) signed definitive documents to acquire Los Sueños Farms LLC for $75 million.

Curaleaf Holdings, Inc. Provides Revenue Guidance for the Second Quarter of 2021

PharmaCann Inc. acquired Elevate Takoma dispensary from Curaleaf Holdings, Inc. (CNSX:CURA).

Curaleaf Holdings, Inc. Completes Reorganization of its Maryland Business

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Maryland Compassionate Care and Wellness LLC.

Curaleaf Holdings, Inc. announced that it has received $130 million in funding

Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven

COO & Treasurer exercised options and sold CA$2.0m worth of stock

Curaleaf Holdings, Inc. Appoints Carlos Madrazo as Senior Vice President Investor Relations and Capital Markets